Skip to main content

Author: College of Medicine, University of Malawi


Contraception: DMPA-SC supplement

This special DMPA-SC supplement of the journal Contraception includes 13 articles authored by several organizations on topics including task-sharing, contraceptive continuation, cost and cost-effectiveness, acceptability and feasibility, storage and disposal, and private sector provision across six countries.

Institutional author(s): World Health Organization (WHO), PATH, FHI 360, Tulane School of Public Health and Tropical Medicine, University of Washington, Institut de Recherche en Sciences et de la Santé, College of Medicine, University of Malawi, Institut Supérieur de Statistiques, Makerere University, Institut Africain de Santé Publique (IASP), University of California San Francisco, École de Santé Publique de Lubumbashi, Population Council
Publication date: 2018

Women’s satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial

To describe women’s experiences with subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to inform scale-up of self-administered DMPA-SC. We conducted a 12-month randomized controlled trial in Malawi to measure DMPA-SC continuation rates. A total of 731 women presenting at six Ministry of Health clinics or to community health workers (CHWs) in rural communities were randomized to receive DMPA-SC administered by a provider or be trained to self-inject DMPA-SC. Data collectors contacted women after the reinjection window at 3, 6 and 9 months to collect data on satisfaction and use; self-injectors were also queried about storage and disposal of DMPA-SC. We compared frequencies of injection experiences and satisfaction by study group and over time.

Institutional author(s): FHI 360, College of Medicine, University of Malawi
Individual author(s): Holly M Burke, Mario Chen, Mercy Buluzi, Rachael Fuchs, Silver Wevill, Lalitha Venkatasubramanian, Leila Dal Santo, Bagrey Ngwira
Publication date: May, 2018

Journal article Contraception journal

Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi

As low- and middle-income countries (LMICs) consider adding self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) to their contraceptive method mix, learning about family planning clients’ and providers’ experiences with self-injectable DMPA-SC during trials will inform introduction and scale-up efforts. We conducted semistructured interviews with 30 randomly selected adult women enrolled in the self-administration group of a 12-month randomized controlled trial studying DMPA-SC continuation rates in rural Malawi. We asked about their experiences learning to self-inject, self-injecting, remembering when to reinject, and storing and disposing of DMPA-SC. We also interviewed 12 providers — clinic-based providers (CBPs) and community-based health surveillance assistants (HSAs) — who trained clients to self-inject DMPA-SC during the trial. We asked about their experiences training and supporting women to self-inject DMPA-SC during the trial and their recommendations for scale-up of self-administered DMPA-SC.

Institutional author(s): FHI 360, College of Medicine, University of Malawi
Individual author(s): Holly M Burke, Catherine Packer, Mercy Buluzi, Elise Healy, Bagrey Ngwira
Publication date: April, 2018

Journal article Link to Journal Article